Author:
Bersani Francesca,Lee Eunjung,Kharchenko Peter V.,Xu Andrew W.,Liu Mingzhu,Xega Kristina,MacKenzie Olivia C.,Brannigan Brian W.,Wittner Ben S.,Jung Hyunchul,Ramaswamy Sridhar,Park Peter J.,Maheswaran Shyamala,Ting David T.,Haber Daniel A.
Abstract
Aberrant transcription of the pericentromeric human satellite II (HSATII) repeat is present in a wide variety of epithelial cancers. In deriving experimental systems to study its deregulation, we observed that HSATII expression is induced in colon cancer cells cultured as xenografts or under nonadherent conditions in vitro, but it is rapidly lost in standard 2D cultures. Unexpectedly, physiological induction of endogenous HSATII RNA, as well as introduction of synthetic HSATII transcripts, generated cDNA intermediates in the form of DNA/RNA hybrids. Single molecule sequencing of tumor xenografts showed that HSATII RNA-derived DNA (rdDNA) molecules are stably incorporated within pericentromeric loci. Suppression of RT activity using small molecule inhibitors reduced HSATII copy gain. Analysis of whole-genome sequencing data revealed that HSATII copy number gain is a common feature in primary human colon tumors and is associated with a lower overall survival. Together, our observations suggest that cancer-associated derepression of specific repetitive sequences can promote their RNA-driven genomic expansion, with potential implications on pericentromeric architecture.
Funder
Howard Hughes Medical Institute
U.S. Department of Defense
HHS | NIH | National Cancer Institute
National Foundation for Cancer Research
Burroughs Wellcome Fund
Susan G. Komen for the Cure
Publisher
Proceedings of the National Academy of Sciences
Cited by
139 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献